Analyst Update: Solaredge, Valeant Pharma, TETRA Technologies

Analysts revised their ratings and price targets on Solaredge Technologies Inc (SEDG), Valeant Pharmaceuticals Intl Inc (VRX), and TETRA Technologies, Inc.(TTI)

May 10, 2016 at 3:16 PM
facebook twitter linkedin

Analysts are weighing in on green energy company Solaredge Technologies Inc (NASDAQ:SEDG), biotech Valeant Pharmaceuticals Intl Inc (NYSE:VRX), and oil stock TETRA Technologies, Inc. (NYSE:TTI). Here's a quick roundup of today's brokerage notes on SEDG, VRX, and TTI.

  • SEDG is down 16% at $18.98, after forecasting lackluster fiscal fourth-quarter revenue -- similar to this sector peer. Goldman Sachs moved its price target to $25, cut the stock's rating from "buy" to "neutral," and removed SEDG from its Americas Conviction Buy list. "We see consistent mis-execution and de-rating in growth prospects at rooftop solar peers limiting near-term upside in shares," Goldman wrote. Echoing that, Deutsche Bank cut SEDG's price target to $27 from $36. Solaredge Technologies Inc is now down more than 34% in 2016, and is now trading south of support in the $22 region. Short sellers have been hot on the solar energy stock, with 19.5% of SEDG's float short-sold, an amount that would take eight days for traders to cover, given SEDG's normal trading volume. Today, however, SEDG is on the short-sale restricted list.
  • VRX is currently down 0.1%, at $28.04.The latest update in the VRX saga is a downgrade by J.P. Morgan Securities, which cut the biotech's price target to $60 from $70. VRX has had a rough year, with shares stair-stepping more than 87% lower since last May. More recently, the stock has struggled to recover from a mid-March bear gap, and touched a five-year low of $25.27 in early April. Options buyers still seem bullish, with Valeant Pharmaceuticals Intl Inc's 10-day call/put volume ratio at the International Securities Exchange (ISE), Chicago Board Options Exchange (CBOE) and NASDAQ OMX PHLX (PHLX) higher than 83% of all other readings from the past year.

  • TTI is up 8.1% at $5.48, a day after gapping roughly 20% lower on earnings. While no fewer than four brokerage firms cut their price targets on TTI, Johnson Rice upgraded the stock to "buy." The stock still has a ways to go before closing yesterday's bear gap, though, prior to which TTI was flirting with $6.20. TETRA Technologies, Inc. has now underperformed the larger S&P 500 Index (SPX) by 25.7 percentage points over the previous 20 sessions. However, its 14-day Relative Strength Index (RSI) sits at 26 -- in oversold territory, suggesting today's bounce may have been in the cards.

For other stocks in analysts' crosshairs, read Analyst Upgrades:, Inc., Baxter International Inc, and OvaScience Inc, and Analyst Downgrades: SolarCity Corp, Gap Inc, and NewLink Genetics Corp.


Begin the New Year With Schaeffer's 7 FREE 2022 Stock Picks!



Special Offers from Schaeffer's Trading Partners